Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive age women

Women of childbearing age sometimes receive prescriptions for potentially teratogenic drugs. Schwarz and coworkers assessed pregnancy rates and frequency of documented contraceptive counseling with prescriptions of class D or X teratogenic drugs filled by 488 175 women in 2001. Prescriptions for class D or X drugs were no more likely to be accompanied by documented claims for contraceptive services or for a subsequent pregnancy than were prescriptions for class A or B drug